很抱歉,您的瀏覽器過於老舊無法閱讀網頁內容的需要,請更新瀏覽器或安裝 Google Chrome.

Investor Relations

Announcement

Senhwa announces the first patient dosed in thephase II study of CX-4945 with Community-AcquiredPneumonia associated with viral infection in Taiwan.

Senhwa announces the first patient dosed in thephase II study of CX-4945 with Community-AcquiredPneumonia associated with viral infection in Taiwan.

Mar
20
2024

Event

Senhwa announces it will be exhibiting at the 2024 American Association for Cancer Research (AACR) Annual Meeting.

Senhwa announces it will be exhibiting at the 2024 American Association for Cancer Research (AACR) Annual Meeting.

  1. Date: 2024-04-05~2024-04-10
  2. Booth No.: Ground Level #1454 (Open 2024-04-08~04-10))
  3. Location: San Diego Convention Center in San Diego, California, USA.
  4. Content: The company’s major focus is engaging with academic and industry researchers as well as with clinicians in person, make new connections, and explore potential collaboration opportunities, which may include cooperation in clinical trials, licensing agreements, introducing late-stage or marketed novel drugs to expand the company's current product line.  Please find details via https://aacr2mapyourshow.com/8_0/exhibitor/exhibitor-details.cfm?exhid=3858885

 

 

Apr
03
2024